LBA2 ALINA: Efficacy and Safety of Adjuvant Alectinib Versus Chemotherapy in Patients with Early-Stage ALK+ Non-Small Cell Lung Cancer (NSCLC)B. J. Solomon,J. S. Ahn,R. Dziadziuszko,F. Barlesi,M. Nishio, D. H. Lee,J. S. Lee,W. Z. Zhong,H. Horinouchi,W. Mao,M. J. Hochmair,F. De Marinis,M. R. Migliorino,I. Bondarenko, T. O. Lohmann, T. Xu, A. Cardona Gavaldon,W. Bordogna, T. Ruf,Y. L. WuAnnals of Oncology(2023)引用 0|浏览33暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要